Metrics to compare | VIROG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVIROGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.2x | 23.7x | −0.5x | |
PEG Ratio | −0.23 | 1.61 | 0.00 | |
Price/Book | 4.9x | 2.0x | 2.6x | |
Price / LTM Sales | 10.7x | 1.9x | 3.2x | |
Upside (Analyst Target) | - | 20.3% | 47.8% | |
Fair Value Upside | Unlock | 23.5% | 5.9% | Unlock |
ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidimetric immunoassay for quantitative measurement of suPAR in human plasma; suPARnostic AUTO Flex ELISA kit, a fully quantitative immunoassay designed for accurate and reliable measurement of soluble urokinase plasminogen activator receptor in human plasma; and suPARnostic Quick Triage, a test for rapid, quantitative measurement of suPAR levels. ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.